United States · Funded startup

Who invested in Tarsus Pharmaceuticals

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$125Mraised across 1 round since 2025, from 1 source

Latest round
Round, $125MMar 2025
Investors
2
See who backed them

The rounds

  1. Mar 2025
    Round$125M

    Source recorded

Founders and team

From Tarsus Pharmaceuticals's own website: 4 on the team.

  • Dianne WhitfieldChief Human Resources Officer
  • Jeff FarrowChief Financial Officer and Chief Strategy Officer
  • Neera ClaseInterim Chief Commercial Officer
  • Historical Price LookupAnalyst Coverage

Everyone who backed them

Vivo CapitalPrivate equity1round
RTW Investments LLCGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Tarsus Pharmaceuticals

Who invested in Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals's investors include Vivo Capital and RTW Investments LLC.

How much has Tarsus Pharmaceuticals raised?

Tarsus Pharmaceuticals has raised $125M across 1 round since 2025.

When did Tarsus Pharmaceuticals last raise?

Tarsus Pharmaceuticals's most recent round was an Undisclosed round of $125M in Mar 2025.

What was Tarsus Pharmaceuticals's biggest round?

Its most recent round, $125M in Mar 2025, is also its largest on record.

Who backed Tarsus Pharmaceuticals first?

Tarsus Pharmaceuticals's first round on record, in Mar 2025, was backed by Vivo Capital and RTW Investments LLC.

What stage is Tarsus Pharmaceuticals at?

Tarsus Pharmaceuticals's latest named round is an Undisclosed round, in Mar 2025.

Where is Tarsus Pharmaceuticals based?

Tarsus Pharmaceuticals is based in the United States.

Companies like Tarsus Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.